Becker's Healthcare December 9, 2025
Curative recently landed over $150 million in series B funding. Now, the COVID-19 testing company-turned-insurer is expanding.
Curative CEO Fred Turner told Becker’s about the company’s choice to move into the Mid-Atlantic region, starting with Maryland and Washington, D.C.
“In particular, Maryland is an attractive state because of the way hospital rates work there, which is more favorable for new entrants,” he said. “We’re not having to negotiate contracts with every single health system to get started.”
Maryland will continue to follow a total cost of care model in 2026, and other states are slated to join in the coming years. The model encourages cross-payer alignment and limits negotiation challenges. Curative has already dispatched its sales team in the region.
...Today's Sponsors
Today's Sponsor